Company / SG&A per Share
ResMed SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$6.75
FY2025
5-year range
$4.63 / $6.75
FY2021-FY2025
Trend
+8.2%
vs FY2024
Sector context
#58 of 150
Health Care
What the data says
At $6.75, ResMed's sg&a per share ranks #93 of 150 in the Health Care sector. SG&A per Share has increased for 4 consecutive years, from $4.63 in FY2021 to $6.75 in FY2025.
Based on SEC 10-K filings.
6.75 in FY2025 with a 5-year CAGR of +7.4%.
Increased from $5.97 to $6.75 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +10.0%
- 5-Year CAGR
- +7.4%
- 10-Year CAGR
- -
Sector benchmark
#93 of 150 in Health CareTop 61% of 150This company $6.75 Sector average $11878.17
▼
-99.9% below sector average
Key checks
Key Insights
- ResMed's sg&a per share has grown for 4 consecutive years.
- In FY2025, sg&a per share increased 8.2% year-over-year.
- Ranks #58 out of 150 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.75 | +8.2% |
| FY2024 | $6.24 | +4.5% |
| FY2023 | $5.97 | +17.9% |
| FY2022 | $5.06 | +9.4% |
| FY2021 | $4.63 | -1.8% |
| FY2020 | $4.71 | +4.2% |
| FY2019 | $4.52 | +7.1% |
| FY2018 | $4.22 | +7.2% |
| FY2017 | $3.94 | +13.4% |
| FY2016 | $3.47 | +1.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026